| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/10/2023 | X4 Pharmaceuticals, Inc | XFOR | Sale | Common Stock | 130.1k | $1.06 | $137.9k | | 08/09/2023 |
| 08/09/2023 | X4 Pharmaceuticals, Inc | XFOR | Grant | Common Stock | 269.9k | $0.00 | $0 | | 08/09/2023 |
| 01/09/2023 | AMARIN CORP PLC\UK | AMRN | Grant | | 182.4k | $0.00 | $0 | | 01/09/2023 |
| 01/09/2023 | AMARIN CORP PLC\UK | AMRN | Grant | Stock Option (Right to Buy) | 223.6k | $1.48 | $330.9k | | 01/09/2023 |
| 06/06/2022 | X4 Pharmaceuticals, Inc | XFOR | Grant | Common Stock | 6.7k | $0.00 | $0 | | 06/06/2022 |
| 06/02/2021 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 6k | $9.50 | $57k | | 06/02/2021 |
| 10/20/2020 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 10k | $7.27 | $72.7k | | 10/20/2020 |
| 06/30/2020 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Grant | Restricted Stock Units | 25k | $0.00 | $0 | | 06/30/2020 |
| 06/10/2020 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 3.4k | $8.69 | $29.8k | | 06/10/2020 |
| 02/14/2020 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Grant | Employee Stock Option (Right to Buy) | 88k | $17.87 | $1.6M | | 02/14/2020 |
| 03/29/2019 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 6.9k | $17.41 | $119.3k | | 03/29/2019 |
| 02/13/2019 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Grant | Employee Stock Option (Right to Buy) | 60k | $29.78 | $1.8M | | 02/13/2019 |
| 10/15/2018 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Grant | Employee Stock Option (right to buy) | 100k | $26.54 | $2.7M | | 10/15/2018 |
| 02/12/2018 | NOVELION THERAPEUTICS INC. | NVLNF | Grant | Stock Option (Right to Buy) | 45k | $0.00 | $0 | | 02/12/2018 |
| 11/27/2017 | NOVELION THERAPEUTICS INC. | NVLNF | Grant | Stock Option (Right to Buy) | 200k | $0.00 | $0 | | 11/27/2017 |
| 11/27/2017 | NOVELION THERAPEUTICS INC. | NVLNF | Grant | Common Stock | 50k | $0.00 | $0 | | 11/27/2017 |